Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

2019177 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Neurology

Volume 18, Issue 9, pp. 845-856

Field-Weighted Citation Impact: 13.52